Drug Shortage Report for DILTIAZEM HYDROCHLORIDE INJECTION

Last updated on 2022-11-23 History
Report ID 168215
Drug Identification Number 02514095
Brand name DILTIAZEM HYDROCHLORIDE INJECTION
Common or Proper name DILTIAZEM HYDROCHLORIDE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 10mL vial / fiole
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2022-06-10
Estimated end date 2022-11-25
Actual end date 2022-11-22
Shortage status Resolved
Updated date 2022-11-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2022-11-23 English Compare
v12 2022-11-22 French Compare
v11 2022-11-22 English Compare
v10 2022-11-18 French Compare
v9 2022-11-18 English Compare
v8 2022-10-20 French Compare
v7 2022-10-20 English Compare
v6 2022-09-23 French Compare
v5 2022-09-23 English Compare
v4 2022-09-18 French Compare
v3 2022-09-18 English Compare
v2 2022-08-30 French Compare
v1 2022-08-30 English Compare

Showing 1 to 13 of 13